🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
352 results for “Viatris”
MedicineActive substanceLicence holderStatus
Detrusitol 1 mg film-coated tablets
PA23355/061/001
Tolterodine tartrate Viatris Healthcare Limited Marketed
Detrusitol 2 mg film-coated tablets
PA23355/061/002
Tolterodine tartrate Viatris Healthcare Limited Marketed
Detrusitol SR 2 mg prolonged-release capsules, hard
PA23355/054/001
Tolterodine tartrate Viatris Healthcare Limited Marketed
Detrusitol SR 4 mg prolonged-release capsules, hard
PA23355/054/002
Tolterodine tartrate Viatris Healthcare Limited Marketed
Diaclide MR 30 mg modified-release tablets
PA23266/033/001
Gliclazide Viatris Limited Marketed
Diaclide MR 60 mg modified-release tablets
PA23266/033/002
Gliclazide Viatris Limited Marketed
Duloxetine Viatris 30 mg hard gastro-resistant capsules
EU/1/15/1010/01-010
Duloxetine hydrochloride Viatris Limited
Duloxetine Viatris 60 mg hard gastro-resistant capsules
EU/1/15/1010/011-020
Duloxetine hydrochloride Viatris Limited
Dutasteride/Tamsulosin hydrochloride 0.5 mg /0.4 mg hard capsules
PA23266/045/001
Dutasteride, Tamsulosin hydrochloride Viatris Limited Marketed
Dymista 137 micrograms/50 micrograms per actuation, Nasal Spray Suspension
PA23355/010/001
Azelastine hydrochloride, Fluticasone propionate Viatris Healthcare Limited Marketed
Efexor XL 150 mg prolonged-release capsules, hard
PA23355/002/003
Venlafaxine hydrochloride Viatris Healthcare Limited Marketed
Efexor XL 37.5 mg prolonged-release capsules, hard
PA23355/002/001
Venlafaxine hydrochloride Viatris Healthcare Limited Marketed
Efexor XL 75 mg prolonged-release capsules, hard
PA23355/002/002
Venlafaxine hydrochloride Viatris Healthcare Limited Marketed
Efudix 5 % w/w Cream
PA23355/026/001
Fluorouracil Viatris Healthcare Limited Marketed
Ejulir 6 mg/ml solution for injection in pre-filled pen
PA23266/080/001
Liraglutide Viatris Limited Not marketed
Eltrombopag Viatris 12.5 mg film-coated tablets
EU/1/24/1869/001-004
Eltrombopag olamine Viatris Limited
Eltrombopag Viatris 25 mg film-coated tablets
EU/1/24/1869/005-008
Eltrombopag olamine Viatris Limited
Eltrombopag Viatris 50 mg film-coated tablets
EU/1/24/1869/009-012
Eltrombopag olamine Viatris Limited
Eltrombopag Viatris 75 mg film-coated tablets
EU/1/24/1869/013-016
Eltrombopag olamine Viatris Limited
Emizof 4 mg film-coated tablets
PA23266/041/001
Ondansetron Viatris Limited Marketed
Emizof 8 mg film-coated tablets
PA23266/041/002
Ondansetron Viatris Limited Marketed
Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris 200 mg/25 mg/25 mg film-coated tablets
EU/1/25/1966/001-006
Emtricitabine, Rilpivirine, Tenofovir alafenamide Viatris Limited
Emtricitabine/Tenofovir alafenamide Viatris 200 mg/10 mg film-coated tablets
EU/1/25/1952/001-002
Emtricitabine Viatris Limited
Emtricitabine/Tenofovir alafenamide Viatris 200 mg/25 mg film-coated tablets
EU/1/25/1952/003-008
Emtricitabine Viatris Limited
Entecavir Viatris 0.5 mg Film-coated tablet
EU/1/17/1227/001-005
Entecavir Viatris Limited
Entecavir Viatris 1 mg film-coated tablets
EU/1/17/1227/006-010
Entecavir Viatris Limited
Enzalutamide Viatris 40 mg Film-coated tablet
EU/1/24/1842/001-003
Enzalutamide Viatris Limited
Enzalutamide Viatris 80 mg Film-coated tablet
EU/1/24/1842/004-006
Enzalutamide Viatris Limited
Epanutin 100 mg Hard Capsules
PA23355/050/003
PHENYTOIN SODIUM Viatris Healthcare Limited Marketed
Epanutin 25 mg Hard Capsules
PA23355/050/001
PHENYTOIN SODIUM Viatris Healthcare Limited Marketed
Epanutin 30 mg/5ml Oral Suspension
PA23355/050/007
Phenytoin Viatris Healthcare Limited Marketed
Epanutin 300 mg Hard Capsules
PA23355/050/004
PHENYTOIN SODIUM Viatris Healthcare Limited Marketed
Epanutin 50 mg Hard Capsules
PA23355/050/002
PHENYTOIN SODIUM Viatris Healthcare Limited Marketed
Epanutin Infatabs 50mg Chewable Tablets
PA23355/050/005
Phenytoin Viatris Healthcare Limited Marketed
Epanutin Ready Mixed Parenteral 250 mg/5 ml Solution for Injection or Infusion
PA23355/050/006
PHENYTOIN SODIUM Viatris Healthcare Limited Marketed
EpiPen 300 micrograms solution for injection in pre-filled pen
PA23355/011/002
Adrenaline Viatris Healthcare Limited Marketed
EpiPen Junior 150 micrograms solution for injection in pre-filled pen
PA23355/011/001
Adrenaline Viatris Healthcare Limited Marketed
Eplerenone Viatris 25 mg film-coated tablets
PA23266/032/001
Eplerenone Viatris Limited Marketed
Escitalpro 10 mg film-coated tablets
PA23266/042/002
Escitalopram Viatris Limited Marketed
Escitalpro 15 mg film-coated tablets
PA23266/042/003
Escitalopram Viatris Limited Marketed
Escitalpro 20 mg film-coated tablets
PA23266/042/004
Escitalopram Viatris Limited Marketed
Escitalpro 5 mg film-coated tablets
PA23266/042/001
Escitalopram Viatris Limited Marketed
Etoricoxib 120 mg film-coated tablets
PA23266/054/004
Etoricoxib Viatris Limited Marketed
Etoricoxib 30 mg film-coated tablets
PA23266/054/001
Etoricoxib Viatris Limited Marketed
Etoricoxib 60 mg film-coated tablets
PA23266/054/002
Etoricoxib Viatris Limited Marketed
Etoricoxib 90 mg film-coated tablets
PA23266/054/003
Etoricoxib Viatris Limited Marketed
Ezetimibe 10 mg tablets
PA23266/050/001
Ezetimibe Viatris Limited Marketed
Faverin 100 mg film-coated tablets
PA23355/024/002
Fluvoxamine maleate Viatris Healthcare Limited Marketed
Faverin 50 mg film-coated tablets
PA23355/024/001
Fluvoxamine maleate Viatris Healthcare Limited Marketed
Febuxostat Viatris 120 mg film-coated tablets
EU/1/17/1194/009-016
Febuxostat Viatris Limited
1 2 3 4 5 6
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.